Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Additional Information (Detail)

v3.22.2.2
Financial Instruments - Additional Information (Detail) - USD ($)
1 Months Ended
Sep. 30, 2022
Nov. 16, 2021
Schedule Of Available For Sale Securities [Line Items]    
Sale of stock price per share   $ 27.74
Other Assets    
Schedule Of Available For Sale Securities [Line Items]    
Strategic investment $ 2,750,000  
Stock Consideration [Member] | PandoLogic Merger Agreement [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Sale of stock price per share $ 20.53  
Minimum [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Contingent earnout $ 10,825,000